Delivery Order SPE2DB20D3303-SPE2DB25FY2A9

Award Date 10/24/24
Potential Completion Date 10/25/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,959.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567027754 - LIDOCAINE 5% PATCH 30S, a medical supply item. The contract is a Firm Fixed Price Delivery Order with a completion date of January 24, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award, valued at $3,822.20, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of LIDOCAINE 5% PATCH 30S, a pharmaceutical product. The contract has an ultimate completion date of October 29, 2024 and is a firm-fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999...
This federal contract award is for the delivery of 4566503338 - LIDOCAINE 5% PATCH 30S to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 20, 2024. The contract has a firm fixed price of $10,803.92 and a period of performance through November 21, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,583.74 firm-fixed-price delivery order is for the supply of 4561971208 - LIDOCAINE 5% PATCH 30S. It has an ultimate completion date of August 29, 2023. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop...
This federal contract award, valued at $1,938.65, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIDOCAINE 5% PATCH 30S, a medical product used in pain management. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
The U.S. Defense Logistics Agency (DLA) awarded a $1,186.46 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation for the supply of 4565597607 - LIDOCAINE 5% PATCH 30S. This delivery order is a part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities...
This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S medical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,200.65, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price and an ultimate completion date of November 7, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) the vendor...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $5,850.57 firm-fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565879217 - LIDOCAINE 5% PATCH 30S. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of medical commodities to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The $4,006.77 firm-fixed-price delivery order is for the supply of LIDOCAINE 5% PATCH 30S, a medical product used to treat pain. The contract has an ultimate completion date of September 11, 2024. Amerisourcebergen has been awarded this contract as a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S to the Medical Supply Chain, a division of the Defense Logistics Agency (DLA). The $17,441.85 firm fixed-price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 23, 2024. The contract is not set aside and has an ultimate completion date of August 26, 2024. This award is likely part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB25FY2A9
    Delivery Order

This federal contract award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is a delivery order for 4566197392 - LIDOCAINE 5% PATCH 30S. The $1,144.64 firm fixed-price contract was awarded to prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 25, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a comprehensive vehicle for providing a range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 1/23/25, 9:16 AM